MYD88 and autoimmune polyendocrinopathy: Our study provides a systematic dissection of the structural heterogeneity of APS and its immunoregulatory network, which operates as a multi-layered system with TLR4/MyD88 as its core, MR/NOD receptors as co-regulators, and T cell reprogramming as the effector mechanism.